Increased incidence of Campylobacter jejuni-associated Guillain- Barré syndromes in the Greater Paris area

Epidemiology and Infection

Volumn 142, Issue 8, 2014, Pages 1609-1613

  Sivadon Tardy, V ^a   Porcher, R ^b   Orlikowski, D ^c   Ronco, E ^c   Gault, E ^a   Roussi, J ^c   Durand, M C ^c   Sharshar, T ^c   Annane, D ^c   Raphael, J C ^c   Megraud, F ^d   Gaillard, J L ^a,c  

^a HÔPITAL AMBROISE PARÉ   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c RAYMOND POINCARÉ HOSPITAL   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Campylobacter; Campylobacter jejuni; Guillain Barr syndrome; Miller Fisher syndrome

Indexed keywords

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BACTERIUM ISOLATION; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; DIARRHEA; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; FRANCE; GUILLAIN BARRE SYNDROME; HOSPITALIZATION; HUMAN; INCIDENCE; NONHUMAN; PRODROMAL SYMPTOM; SEASONAL VARIATION; SEROLOGY; TIME SERIES ANALYSIS; TREND STUDY; ADULT; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL FEATURE; COHORT ANALYSIS; COMPLEMENT FIXATION TEST; DATA ANALYSIS; DIAGNOSTIC TEST; FECES CULTURE; FEMALE; GEOGRAPHIC DISTRIBUTION; HOSPITAL ADMISSION; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; POPULATION RESEARCH; PREVALENCE; PUBLIC HEALTH; PUBLIC-PRIVATE PARTNERSHIP; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

GANGLIOSIDE GM1 ANTIBODY;

ADULT; AGED; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; FEMALE; FRANCE; GUILLAIN-BARRE SYNDROME; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PARIS;

EID: 84902470129     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026881300263X     Document Type: Article

References (16)

1. Hughes RA, Rees JH. Clinical and epidemiologic features of Guillain-Barré syndrome. Journal of Infectious Diseases 1997; 176 (Suppl. 2): S92-98.
2. Rees JH, et al. Campylobacter jejuni infection and Guillain-Barré syndrome. New England Journal of Medicine 1995; 333: 1374-1379.
3. Hadden RD, et al. Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology 2001; 56: 758-765.
4. Van Koningsveld R, et al. Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands. Neurology 2000; 54: 620-625.
5. Sivadon-Tardy V, et al. Guillain-Barré syndrome, greater Paris area. Emerging Infectious Diseases 2006; 12: 990-993.
6. Plasma Exchange Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997; 349: 225-230.
7. Sivadon-Tardy V, et al. Detection of Campylobacter jejuni by culture and real-time PCR in a French cohort of patients with Guillain-Barré syndrome. Journal of Clinical Microbiology 2010; 48: 2278-2281.
8. Sivadon-Tardy V, et al. Guillain-Barré syndrome and influenza virus infection. Clinical Infectious Diseases 2009; 48: 48-56.
9. Orlikowski D, et al. Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study. Clinical Infectious Diseases 2011; 52: 837-844.
10. Jones RH, Ford PM, Hamman RF. Seasonality comparisons among groups using incidence data. Biometrics 1988; 44: 1131-1144.
11. Nylen G, et al. The seasonal distribution of campylo-bacter infection in nine European countries and New Zealand. Epidemiology and Infection 2002; 128: 383-390.
12. Altekruse SF, et al. Campylobacter jejuni-an emerging foodborne pathogen. Emerging Infectious Diseases 1999; 5: 28-35.
13. Gallay A, et al. Risk factors for acquiring sporadic Campylobacter infection in France: results from a national case-control study. Journal of Infectious Diseases 2008; 197: 1477-1484.
14. Tauxe RV, et al. Campylobacter isolates in the United States, 1982-1986. Morbidity and Mortality Weekly Report. CDC Surveillance Summaries 1988; 37: 1-13.
15. Taylor EV, et al. Common source outbreaks of Campylobacter infection in the USA, 1997-2008. Epidemiology and Infection 2012; 15: 1-10.
16. Baker M, et al. Declining Guillain-Barré syndrome after campylobacteriosis control, New-Zealand, 1988-2010. Emerging Infectious Diseases 2012; 18: 226-233.